Results 301 to 310 of about 14,301,803 (394)

Placebo effect in the management of chronic pain. [PDF]

BJA Educ, 2020
Perfitt JS, Plunkett N, Jones S.
europepmc   +1 more source

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

, 2001
J Thambyrajah, Martin Landray, Heather J. Jones, Fiona J McGlynn, David C. Wheeler, John Townend   +5 more
openalex   +1 more source

Placebo effect of medication cost in Parkinson disease

Neurology, 2015
A. Espay, Matthew M. Norris, J. Eliassen, A. Dwivedi, Matthew S. Smith, C. Banks, J. Allendorfer, A. Lang, D. Fleck, Michael J. Linke, J. Szaflarski   +10 more
semanticscholar   +1 more source

Counting your chickens before they hatch: improvements in an untreated chronic pain population, beyond regression to the mean and the placebo effect. [PDF]

Pain Rep
Sean M, Coulombe-Lévêque A, Nadeau W, Charest AC, Martel M, Léonard G, Tétreault P.   +6 more
europepmc   +1 more source

Pathological Disulfide Bond Crosslinking: Molecular Insights into Amyloidogenesis and Diseases Progression

ChemBioChem, EarlyView.
This review explores pathological disulfide‐crosslinking as a key driver of amyloidogenic protein misfolding and aggregation. Oxidative and ER stress pathways contributing to disease progression are discussed and emerging therapeutic strategies targeting disulfide‐linked aggregates in neurodegenerative and systemic amyloid diseases are examined ...
Dong Min Kang, Nataliia Lukianenko, Ja‐Hyun Baik, Yun Kyung Kim, Sungsu Lim   +4 more
wiley   +1 more source

Hijacking the Electron Train: Menaquinone‐Binding Antimicrobial Peptides

ChemBioChem, EarlyView.
Menaquinone is an emerging target for antimicrobial peptides. Could it be the new Achilles’ Heel of bacteria? The rise of antibiotic resistance threatens to undermine modern medicine, making the development of new antibiotics and novel targets an urgent priority.
Eilidh J. Matheson, Stephen A. Cochrane
wiley   +1 more source

Confusing placebo effect with natural history in epilepsy: A big data approach

Annals of Neurology, 2015
D. Goldenholz, Robert Moss, Jonathan M Scott, S. Auh, W. Theodore   +4 more
semanticscholar   +1 more source

Two‐Year Results of Percutaneous Endocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Hypertrophic obstructive cardiomyopathy (HOCM) is a hereditary myocardial disease. Percutaneous endocardial septal radiofrequency ablation (PESA) is an innovative approach for treating HOCM. Consequently, we present the outcomes of the PESA for HOCM. Methods This study included 20 patients with HOCM who received PESA.
NingNing Zheng, YiYuan Chen, YongBing Fu, Feng Xue, FangFang Zhang, Lin Ling, TingBo Jiang   +6 more
wiley   +1 more source

Randomized Placebo-Controlled Trial to Assess the Effect of Remifentanil and Propofol on Bispectral Index and Sedation

, 2001
NULL AUTHOR_ID
openalex   +1 more source

Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early‐Phase Clinical Study Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Clascoterone is an androgen receptor inhibitor approved for the treatment of acne vulgaris in patients 12 years of age and older. Here, we report results of 5 phase 1 studies that assessed the pharmacokinetics (PK), safety, and skin irritation and sensitization potential of clascoterone cream 1% in healthy participants and patients with acne ...
Andrea Francesco Daniele Di Stefano, Milko Massimiliano Radicioni, Gerhard Garhöfer, Martina Cartwright, Markus Müller, Iris Kopeloff, Luigi Moro, Nicholas Squittieri, Alessandro Mazzetti   +8 more
wiley   +1 more source